1. Introduction

---

Hemangioma is the most common primary tumor of the liver .The Liver hemangiomas are usually diagnosed incidentally, and most of them are small (< 1 cm in diameter) .The hemangioma is qualified giant when having a diameter larger than 5 cm. Observation. Asymptomatic giant liver hemangiomas even very large lesions can be safely observed with low rate of adverse events [1] .However the indications of surgery for giant liver hemangioma are well defined. When surgery , which isthe most effective treatment procedure, is indicated, giant liver hemangioma can be excised by resection or enucleation with a low risk of morbidity and mortality[1,2,3] .

2. Enucleation Versus Resection

---

The management of giant liver hemangioma (GLH) varies from observation to a variety of nonsurgical and surgical procedures. Asymptomatic giant liver hemangioma (GLH ) is managed conservatively even in patients with extremely large hepatic hemangiomas by supervision through regular imaging control with lower risk of adverse events[1] . However, surgical options including enucleation, liver resection, and liver transplantation can be considered to treat GLH surgically. These surgical procedures are more radical than the nonsurgical methods and allow histologic examination of the specimen [2].Surgical excision is indicated in case of symptomatic or complicated lesions. Thus symptomatic giant hemangioma with severe progressive symptoms not medically controlled, Consumptive coagulopathy or Kasabach-Merrittsyndrome which is characterized by thrombocytopenia secondary to platelet sequestration and destruction within the hemangioma, and spontaneous rupture with bleeding are commonly the most indication for surgery [3-8]. The rapid growth tumor is considered as an indication for surgery however a minimum of 25% increase in largest diameter over a period of 6 months is required to justify surgical treatment for asymptomatic hemangiomas [7,9-13]. Diagnostic uncertainty with inability to exclude malignancy was another criterion for surgery, but the diagnostic certainty is currently established in most cases with combined use of advanced various imaging techniques [14-16].

Although there is no agreement on the optimal management for giant liver hemangioma, surgery remains the most effective therapeutic modality for treatment [17] .When surgery is indicated, the surgical excision is the most effective procedure to treat hemangioma .Thus resection and enucleation are the two most used surgical procedures to surgically treat liver hemangioma with very low associated morbidity and mortality .Some authors advocate liver resection [18,19], but others advocate enucleation [2,20,21].

Liver resection is the first surgical procedure used to treat hemangioma. Since Couinaud defined the segmental anatomy and the avascular planes; performing hepatectomy had become a safer surgical procedure. Hepatic resection can be anatomic or nonanatomic .However anatomic resections are preferred by authors because it is associated with reduced intraoperative blood loss and reduced need to red cell transfusion [12,22]. Originally, resection was the surgical procedure of choice to treat liver hemangioma until the first description of enucleation technique by Alper et al. in 1988 [2]. The enucleation technique is based on the macroscopic observation that hemangiomas are encapsulated by a dissection plane separating hemangioma and liver parenchyma [23]. The presence of this definite and easily separable cleavage plane makes ligation of vessels entering or leaving the hepatic hemangioma much simpler and decreases the risk of intraoperative bleeding and blood loss. Also the absence of bile ducts in the enucleation dissection plane reduces the risk of postoperative bile leak .Moreover enucleation preserves more healthy liver parenchyma avoiding unnecessary parenchyma loss for the treatment of benign tumor [7,17].Compared to peripherally located hamangiomas, enucleation of centrally located hamangiomas is more likely associated with longer operative time and higher rate of blood loss and transfusion [24]. However , the risk of bleeding and blood transfusions is to be more related to hemangioma size than to the type of surgical technique [11,25].Thus blood transfusion was more needed in patients with hamangiomas larger than 10 cm in size[12].

The choice of resection or enucleation of giant liver hemangioma (GLH) is mainly dependent on the location, size and number of lesions, as well as preference and technical skill of the surgeon [26,27]. Enucleation procedure is indicated when the fibrous tissue separating hemangioma and surrounding normal liver parenchyma is easily recognizable and cleavable; and also in case of peripheral and right-sided location of hemangioma and in an intent to preserve more normal liver parenchyma[11]. Regarding the progress made in liver surgery, enucleation meets the requirement of precise liver surgery which is precision, minimal invasiveness, and effectiveness and it can thus be adopted by more and more surgeons [28].Recent reported meta-analyses [29,30] comparing outcomes of enucleation versus those of anatomic resection of GLH concluded that , there was no surgery –related death in either the enucleation or the anatomic resection procedure , and enucleation was associated with significantly lower blood loss, lower surgical time, and lower risk of complications. Therefore, performing enucleation is simpler than resection with reduced operative blood loss due to the presence of easily cleavable dissection plane between hemangioma and normal liver parenchyma, and with lower morbidity[31]. Enucleation is advocated by most authors because it is safer and quiker with lower overall complications and less blood loss [26,32-34].

3. Conclusion

---

Giant liver hemangioma can be removed safely by either enucleation or anatomic resection. Enucleation preserves more normal liver parenchyma, decreases operative blood loss and reduces postoperative complications. Therefore enucleation may become the preferable choice for surgeons and it should be the preferred surgical procedure for suitable lesions.

---

References

---

1. Bajenaru N, Balaban V, Savulescu F, Campeanu I, Patrascu T: Hepatic hemangioma – review. J Med Life 2015; 8(spec issue):4–11.
2. Alper A, Ariogul O, Emre A, Uras A, Okten A: Treatment of liver hemangiomas by enucleation. Arch Surg 1988; 123:660–661
3. Hoekstra LT, Bieze M, Erdogan D, Roelofs JJ, Beuers UH, van Gulik TM: Management of giant liver hemangiomas: an update. Expert Rev Gastroenterol Hepatol 2013; 7: 263–268.
4. Yedibela S, Alibek S, Müller V, et al. Management of hemangioma of the liver: surgical therapy or observation? World J Surg. 2013; 37:1303.
5. Hall GW: Kasabach-Merritt syndrome: pathogenesis and management. Br J Haematol 2001; 112: 851–862.
6. Terkivatan T, Vrijland WW, Den Hoed PT, et al. Size of lesion is not a criterion for resection during management of giant liver haemangioma. Br J Surg. 2002; 89:1240.
7. Ozden EA, Alper A, Tunaci M et al (2000) Long term result of surgery for liver hemangiomas.Arch Surg 135:978–981
8. Kammula US, Buell JF, Labow DM (2001) surgical management of benign tumors of liver. Int J Gastrointest Cancer 30:141–146
9. Pietrabissa A, Giulianotti P, Campatelli A, et al. Management and follow-up of 78 giant haemangiomas of the liver. Br J Surg. 1996;83:915.
10. Meguro M, Soejima Y, Taketomi A, et al. Living donor liver transplantation in a patient with giant hepatic hemangioma complicated by Kasabach-Merritt syndrome: report of a case. Surg Today. 2008; 38:463.
11. Giuliante F, Ardito F, Vellone M, et al. Reappraisal of surgical indications and approach for
12. liver hemangioma: single-center experience on 74 patients. Am J Surg. 2011; 201:741-48.
13. Yedibela S, Alibek S, Müller V, et al. Management of hemangioma of the liver: surgical therapy or observation? World J Surg. 2013; 37:1303.
14. Terkivatan T, Vrijland WW, Den Hoed PT, et al. Size of lesion is not a criterion for resection during management of giant liver haemangioma. Br J Surg. 2002; 89:1240.
15. Mezhir JJ, Fourman LT, Do RK, et al. Changes in the management of benign liver tumours: an analysis of 285 patients. HPB. 2013; 15:156.
16. Weimann A, Ringe B, Klempnauer J et al (1997) benign liver tumors: differential diagnosis and indications for surgery. World J Surg 21:983–990
17. D’Angelica M (2013) What’s riskier for the patient with an asymptomatic large hepatic hemangioma:observation or the surgeon? World J Surg 37:1313–1314
18. Yoon SS, Charny CK, Fong Y, Jarnagin WR, Schwartz LH, Blumgart LH, DeMatteo RP: Diagnosis, management, and outcomes of 115 patients with hepatic hemangioma. J Am Coll Surg 2003; 197:392–402.
19. Borgonovo G, Razzetta F, Arezzo A, et al. Giant hemangiomas of the liver: Surgical treatment by liver resection. Hepatogastroenterology 1997;44:231–244
20. Brouwers MA, Peeters PM, de Jong KP, et al. Surgical management of giant haemangioma of the liver. Br. J. Surg. 1997;84:314–316
21. Baer HU, Dennison AR, Mouton W, et al. Enucleation of giant hemangiomas of the liver. Technical and pathologic aspects of a neglected procedure. Ann. Surg. 1992;216:673–676
22. Alper A, Ariogul O, Emre A, et al. Treatment of liver hemangiomas by enucleation. Arch. Surg. 1988;123:660–661
23. Kuo PC, Lewis WD, Jenkins RL. Treatment of giant hemangiomas of the liver by enucleation. J. Am. Coll. Surg. 1994;178:49–53
24. Patriti A, Graziosi L, Sanna A, Gullà N, Donini A. Laparoscopictreatmentofliver hemangioma.Surg Laparosc Endosc Percutaneous Tech. 2005;15:359.
25. Demiryürek H, Alabaz O, Ağdemir D, Sungur I, Erkoçak EU, Akinoğlu A, Alparslan A,Zorludemir S: Symptomatic giant cavernous haemangioma of the liver: is enucleation a safe method? A single institution report. HPB Surg 1997; 10:299–304.
26. Yoon SS, Charny CK, Fong Y, et al. Diagnosis, management, and outcomes of 115 patients with hepatic hemangioma. J Am Coll Surg. 2003; 197:392.
27. Fu XH, Lai EC, Yao XP et al (2009) Enucleation of liver hemangiomas: is there a difference in surgical outcomes for centrally or peripherally located lesions? Am J Surg 198:184–187
28. Longeville JH, de la Hall P, Dolan P, et al. Treatment of a giant haemangioma of the liver with Kasabach-Merritt syndrome by orthotopic liver transplant a case report. HPB Surg. 1997; 10:159.
29. Hamaloglu E, Altun H, Ozdemir A, Ozenc A: Giant liver hemangioma: therapy by enucleation or liver resection. World J Surg 2005; 29:890–893.
30. Lerner SM, Hiatt JR, Salamandra J, Chen PW, Farmer DG, Ghobrial RM, Busuttil RW: Giant cavernous liver hemangiomas: effect of operative approach on outcome. Arch Surg 2004;139:818–821
31. Giuliante F, Ardito F, Vellone M, Giordano M, Ranucci G, Piccoli M, Giovannini I, Chiarla C, Nuzzo G: Reappraisal of surgical indications and approach for liver hemangioma: single-center experience on 74 patients. Am J Surg 2011; 201:741– 748
32. Dong J: Precision liver surgery. Chin J Dig Surg 2014; 13:405–411.
33. Yuhui Liu, Xuyong Wei, Kun Wang, Qiaonan Shan, Haojiang Dai , Haiyang Xie :Enucleation versus Anatomic Resection for Giant Hepatic Hemangioma: A Meta-Analysis. Gastrointest Tumors, 2016; 3:153–162.
34. WL Cheng, YQ Qi B, Wang L, Tian W,Huang Y, chen: Enucleation versus hepatectomy for giant hepatic haemangiomas: a meta-analysis.RCS annals J , 2017 ; 99 (3): 237-241.
35. Zimmermann A, Baer HU: Fibrous tumor-liver interface in large hepatic neoplasms: its significance for tumor resection and enucleation. Liver Transpl Surg 1996; 2:192– 199.
36. Gedaly R, Pomposelli JJ, Pomfret EA, Lewis WD, Jenkins RL: Cavernous hemangioma of the liver: anatomic resection vs. enucleation. Arch Surg 1999; 134:407–411.
37. Hamaloglu E, Altun H, Ozdemir A, Ozenc A: Giant liver hemangioma: therapy by enucleation or liver resection. World J Surg 2005;29:890–893
38. Singh RK, Kapoor S, Sahni P, Chattopadhyay TK: Giant haemangioma of the liver: is enucleation better than resection? Ann R Coll Surg Engl 2007; 89:490–493.
39. Qiu J, Chen S, Wu H: Quality of life can be improved by surgical management of giant hepatic haemangioma with enucleation as the preferred option. HPB (Oxford) 2015; 17: 490– 494.